with kidney disease in 2005 were [65 years old. The same incidence was 49.9% in 1980 [9] . These data provide another proof of the rising incidence of chronic kidney disease (CKD) in the elderly. An increase of approximately 300% (from 19.3 to 56.2 per 10,000 population) occurred among persons aged 65-74 and an increase of approximately 350% (from 119.0 to 393.2 per 10,000 population) occurred among persons aged [75 [9] . Kidney disease was the 9th leading cause of death in the United States in 2005 with nearly 26,000,000 persons having CKD, and another 20,000,000 being at increased risk for CKD [9] . ESRD causes approximately 85,000 deaths each year in the United States [9] .
Several issues vary between younger and elderly patients. The possible vascular access options in elderly patients with ESRD should not be different from younger individuals [10] . However, access to renal transplantation is limited considerably by increasing age [11, 12] . Furthermore, older patients with CKD often report a worse quality-of-life than younger individuals [13, 14] ; although elderly patients may often adjust to dialysis psychosocially better than younger individuals, the losses in physical and cognitive function may challenge the quality-oflife in a large percentage of them [13, 14] . In addition, CKD is associated with an increased risk for cardiovascular complications and cardiovascular disease mortality [15, 16] . Furthermore, with growing age, the immune system is influenced in both qualitative and quantitative manner, making these patients more susceptible to infection and sepsis [17] . Probably, as a result of this, dialysis does not provide a survival benefit in elderly patients with ESRD and several co-morbidities [15, 16] . All the above issues constitute important parameters when considering the effect of ESRD on economies around the globe. Patients with ESRD consume a considerable part of a country's budget on health; apparently, this percent is going to increase as the years go by. The total annual cost of treating ESRD patients in the United States was estimated to be $33 billion in 2009 [9] .
Several solutions to this growing global problem have been proposed, such as renal management clinics, where preventive measures (e.g. optimal management of diabetes mellitus and hypertension with drugs and life-style measures) to delay progression of renal failure should be expanded and applied to all patients with CKD stages 3 and 4 [18] . Also, home dialysis [19] and dialysis in nursing homes with extended care facilities [20] offer treatment for elderly patients without family support; these alternatives may prove to be better options than in-hospital dialysis. Another option for frail and physically dependent elderly patients with ESRD may be assisted automated peritoneal dialysis [21] or assisted peritoneal dialysis for the elderly [22] . These options utilize the assistance of home-care nurses and family members [21, 22] . Patients with many comorbidities who cannot perform peritoneal exchange by themselves are offered considerable advantages with automated peritoneal dialysis since this limits home-care nurse visits to only two a day. Automated peritoneal dialysis keeps the patient's daytime free for nursing home activities, increases socialization and enables better rehabilitation that improves the quality-of-life of these individuals [22] . Some of these may contribute to the reduction in costs for dialysis patients. Others may actually increase costs. All these suggestions, however, need to be tested extensively before applying them to an organized health system.
Another important issue that needs to be taken into consideration is the cost-effectiveness of the dialysis method. A recent analysis of the cost of different dialysis modalities in UK hospitals showed that the most cost-effective modalities are continuous ambulatory peritoneal dialysis and automated peritoneal dialysis, with mean annual costs of £15,570 and £21,655, respectively. In contrast, hospital-based hemodialysis and satellite-unit-based hemodialysis were not cost-effective, with mean annual costs of £35,023 and £32,669, respectively [23] . A systematic review of the literature regarding the cost-effectiveness of dialysis treatment modalities demonstrated that hemodialysis is indeed a more expensive option than peritoneal dialysis [24] .
In conclusion, the incidence of CKD stages 3-5 in the elderly is increasing around the world with every year. This increase holds considerable socioeconomic consequences for health economies worldwide. Thus, it is important to employ measures to reduce mortality rates in this population. There is an urgent need for a solution to this new epidemic by governments in collaboration with the Nephrology community around the world before its weight on global economy becomes unbearable.
